Tanenbaum Dermatology Center
Memphis, Tennessee, United States
Dermatologist in Memphis, Tennessee
760 E Brookhaven Cir, Memphis, TN 38117
About Tanenbaum Dermatology Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
3
Clinical Trials at Tanenbaum Dermatology Center
During the past decade, Tanenbaum Dermatology Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
2018-03-08
2025-06-30
Active, not recruiting
3,163
Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis
2018-06-29
2019-08-13
Completed
391
Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis
2019-05-13
2020-05-07
Completed
292
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Tanenbaum Dermatology Center
According to Clinical.Site data, the most researched conditions in "Tanenbaum Dermatology Center" are
"Dermatitis, Atopic" (2 trials) and "Atopic Dermatitis" (1 trials). Many other conditions were trialed in "Tanenbaum Dermatology Center" in a lesser frequency.
Clinical Trials Intervention Types at Tanenbaum Dermatology Center
Most popular intervention types in "Tanenbaum Dermatology Center" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Abrocitinib 100 mg" (1 trials), "Abrocitinib 200 mg" (1 trials), "PF-04965842 100 mg" (1 trials) and "PF-04965842 200 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Tanenbaum Dermatology Center
The vast majority of trials in "Tanenbaum Dermatology Center" are
3 trials for "All" genders.
Clinical Trials Status at Tanenbaum Dermatology Center
Currently, there are NaN active trials in "Tanenbaum Dermatology Center".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Tanenbaum Dermatology Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Tanenbaum Dermatology Center, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".